Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: To all: I've noticed that some posters are asking

I agree with opty. They won't need to buyback at $2 a share. If we aren't going to do anything for a while, buy back shares is better than doing nothing.They could in fact give those shares as part of a package in the acquisition process.

Regards

Share
New Message
Please login to post a reply